AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Incresit M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sydmen Lifesciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Incresit M 50mg/500mg Tablet

Diabetic patients with type 2 mellitus can manage elevated blood glucose with the dual-action Incresit M 50mg/500mg Tablet. This medication mitigates serious diabetic complications like vision impairment and nephropathy, potentially lowering stroke and heart attack risks. Incresit M 50mg/500mg Tablets may be used independently or in conjunction with other anti-diabetic therapies, and are most effective when paired with diet and exercise. Dosage is tailored to individual needs, considering current health, glucose levels, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent, daily administration at the same time maximizes efficacy and should not cease without physician approval. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes control, as lifestyle significantly impacts management. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; understanding its symptoms and treatment is essential. Prior consultation with your doctor is mandatory if you have pre-existing liver, kidney, or heart conditions, pancreatic issues, or consume excessive alcohol. This also applies to pregnant or lactating individuals. Inform your physician about all medications you are currently using, as interactions may occur. Alcohol consumption should be limited due to its potential to decrease blood glucose. Regular monitoring of kidney function and blood sugar levels will be conducted by your doctor throughout treatment.

Primary Ingredients of Incresit M 50mg/500mg Tablet

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Incresit M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Incresit M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 50mg/500mg Incresit M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Incresit M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Incresit M 50mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 50mg/500mg Incresit M tablet whole; avoid chewing, crushing, or fracturing it. Consume with a meal.

How Incresit M 50mg/500mg Tablet works:

Incresit M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and decreases hepatic glucose production. Metformin, a biguanide, reduces glucose output by the liver, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Incresit M 50mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Incresit M 50mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Incresit M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Incresit M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Incresit M 50mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Incresit M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Incresit M 50mg/500mg Tablet :

Should you forget a dose of Incresit M 50mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Incresit M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Incresit M 50mg/500mg Tablet

Incresit M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Incresit M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Incresit M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Incresit M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Incresit M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Incresit M 50mg/500mg Tablet. This occurs due to excessive lactic acid buildup in the blood. Because it's rare, its use is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Incresit M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Incresit M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Incresit M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Incresit M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Metformin, a component of Incresit M 50mg/500mg Tablet, can rarely cause lactic acidosis (MALA—Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Incresit M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Incresit M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Incresit M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients allergic to Incresit M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Incresit M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Incresit M 50mg/500mg Tablet. This occurs due to excessive lactic acid buildup in the blood. Because of this risk, Incresit M is contraindicated in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Incresit M and seek immediate medical attention.
Prolonged use of Incresit M 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Incresit M 50mg/500mg Tab...
193